See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: June 19, 2006

Crohn's Disease Non-Small Cell Lung Cancer Claudication

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Crohn's Disease

To qualify for this research study of an investigational drug, you must be at least 18 years old and have confirmed Crohn's disease.

The research site is in Mineola, NY.

More information

Please see http://www.centerwatch.com/patient/studies/cat51.html.

-----

Non-Small Cell Lung Cancer

This study is for people with advanced non-small cell lung cancer. Candidates 18 or older with histologically or cytologically confirmed inoperable NSCLC (stage IIIB/IV) who have failed or relapsed after receiving platinum-based chemotherapy as first-line therapy may qualify.

The research site is in Worcester, Mass.

More information

Please see http://www.centerwatch.com/patient/studies/cat683.html.

-----

Claudication

Do you experience leg pain while walking or exercising? You may have intermittent claudication, a symptom of peripheral arterial disease (PAD). To qualify for the study, you must be at least 40, have recurring leg pain relieved by rest, and have limited walking ability due to pain. If you are not sure your leg pain is caused by intermittent claudication, a study physician can perform a diagnostic test.

The research site is in Santa Rosa, Calif.

More information

Please see http://www.centerwatch.com/patient/studies/cat391.html.

-----

Copyright 2006 Thomson CenterWatch. All rights reserved.

Consumer News
undefined
undefinedundefined